Management of antithrombotic agents and current issues in patients undergoing endoscopic submucosal dissection

키워드

참고문헌 (43)

1. Park CH, "Clinical safety of endoscopic submucosal dissection compared with surgery in elderly patients with early gastric cancer: a propensity-matched analysis", Gastrointest Endosc, 80, pp.599~609 (2014)
2. Park CH, "Long-term outcome of early gastric cancer after endoscopic submucosal dissection : expanded indication is comparable to absolute indication", Dig Liver Dis, 45, pp.651~656 (2013)
3. Daoud DC, "Comparing outcomes for endoscopic submucosal dissection between Eastern and Western countries : a systematic review and meta-analysis", World J Gastroenterol, 24, pp.2518~2536 (2018)
4. Cao Y, "Meta-analysis of endoscopic submucosal dissection versus endoscopic mucosal resection for tumors of the gastrointestinal tract", Endoscopy, 41, pp.751~757 (2009)
5. 박찬혁, "Preventing and Controlling Bleeding in Gastric Endoscopic Submucosal Dissection", Clinical Endoscopy, 46(5), pp.456~462 (2013), 대한소화기내시경학회
6. Kim EH, "Role of second-look endoscopy and prophylactic hemostasis after gastric endoscopic submucosal dissection:a systematic review and meta-analysis", J Gastroenterol Hepatol, 32, pp.756~768 (2017)
7. Oda I, "Complications of gastric endoscopic submucosal dissection", Dig Endosc, 25(Suppl 1), pp.71~78 (2013)
8. Toyonaga T, "1, 635 Endoscopic submucosal dissection cases in the esophagus, stomach, and colorectum : complication rates and long-term outcomes", Surg Endosc, 27, pp.1000~1008 (2013)
9. Saito Y, "Endoscopic treatment of large superficial colorectal tumors : a case series of 200 endoscopic submucosal dissections(with video)", Gastrointest Endosc, 66, pp.966~973 (2007)
10. Fujishiro M, "Outcomes of endoscopic submucosal dissection for colorectal epithelial neoplasms in 200 consecutive cases", Clin Gastroenterol Hepatol, 5, pp.678~683 (2007)
11. Saito Y, "A prospective, multicenter study of 1111 colorectal endoscopic submucosal dissections (with video)", Gastrointest Endosc, 72, pp.1217~1225 (2010)
12. Terasaki M, "Risk factors for delayed bleeding after endoscopic submucosal dissection for colorectal neoplasms", Int J Colorectal Dis, 29, pp.877~882 (2014)
13. Isomoto H, "Management of complications associated with endoscopic submucosal dissection", endoscopic mucosal resection for esophageal cancer, 2013, pp.25(Suppl 1), 29~38
14. Kagemoto K, "Clinical outcomes of endoscopic submucosal dissection for superficial Barrett’s adenocarcinoma", Gastrointest Endosc, 80, pp.239~245 (2014)
15. Béjot Y, "Impact of the ageing population on the burden of stroke: the Dijon Stroke Registry", Neuroepidemiology, 52, pp.78~85 (2019)
16. Chugh SS, "Global burden of atrial fibrillation in developed and developing nations", Glob Heart, 9, pp.113~119 (2014)
17. ASGE Standards of Practice Committee, "The management of antithrombotic agents for patients undergoing GI endoscopy", Gastrointest Endosc, 83, pp.3~16 (2016)
18. ASGE Standards of Practice Committee, "Management of antithrombotic agents for endoscopic procedures", Gastrointest Endosc, 70, pp.1060~1070 (2009)
19. Boustière C, "Endoscopy and antiplatelet agents. European Society of Gastrointestinal Endoscopy (ESGE) Guideline", Endoscopy, 43, pp.445~461 (2011)
20. Veitch AM, "Endoscopy in patients on antiplatelet or anticoagulant therapy, including direct oral anticoagulants: British Society of Gastroenterology (BSG) and European Society of Gastrointestinal Endoscopy (ESGE) guidelines", Gut, 65, pp.374~389 (2016)
21. Fujimoto K, "Guidelines for gastroenterological endoscopy in patients undergoing antithrombotic treatment", Dig Endosc, 26, pp.1~14 (2014)
22. Kato M, "Guidelines for gastroenterological endoscopy in patients undergoing antithrombotic treatment : 2017 appendix on anticoagulants including direct oral anticoagulants", Dig Endosc, 30, pp.433~440 (2018)
23. Chan FKL, "Management of patients on antithrombotic agents undergoing emergency and elective endoscopy:joint Asian Pacific Association of Gastroenterology (APAGE) and Asian Pacific Society for Digestive Endoscopy (APSDE) practice guidelines", Gut, 67, pp.405~417 (2018)
24. Venkat Nutalapati, "Development and validation of a web-based electronic application in managing antithrombotic agents in patients undergoing GI endoscopy", Gastrointestinal Endoscopy, 90(6), pp.906~912 (2019), Elsevier BV[DOI]
25. Lee SY, "Managing anticoagulation and antiplatelet medications in GI endoscopy: a survey comparing the East and the West", Gastrointest Endosc, 67, pp.1076~1081 (2008)
26. Lee SY, "The type of the patient should be considered on discontinuation of anticoagulant and antiplatelet therapy", Gut, 58, pp.153~154 (2009)
27. Sanomura Y, "Continued use of low-dose aspirin does not increase the risk of bleeding during or after endoscopic submucosal dissection for early gastric cancer", Gastric Cancer, 17, pp.489~496 (2014)
28. Tounou S, "Continuous aspirin use does not increase postendoscopic dissection bleeding risk for gastric neoplasms in patients on antiplatelet therapy", Endosc Int Open, 3, pp.E31~E38 (2015)
29. Igarashi K, "Should antithrombotic therapy be stopped in patients undergoing gastric endoscopic submucosal dissection?", Surg Endosc, 31, pp.1746~1753 (2017)
30. Jaruvongvanich V, "Continued versus interrupted aspirin use and bleeding risk after endoscopic submucosal dissection of gastric neoplasms : a meta-analysis", Ann Gastroenterol, 31, pp.344~349 (2018)
31. Cho SJ, "Aspirin use and bleeding risk after endoscopic submucosal dissection in patients with gastric neoplasms", Endoscopy, 44, pp.114~121 (2012)
32. Harada H, "Feasibility of gastric endoscopic submucosal dissection with continuous low-dose aspirin for patients receiving dual antiplatelet therapy", World J Gastroenterol, 25, pp.457~468 (2019)
33. Morimoto T, "Application of U.S. guidelines in other countries: aspirin for the primary prevention of cardiovascular events in Japan", Am J Med, 117, pp.459~468 (2004)
34. Takahashi H, "Population differences in S-warfarin metabolism between CYP2C9 genotype-matched Caucasian and Japanese patients", Clin Pharmacol Ther, 73, pp.253~263 (2003)
35. Takahashi H, "Different contributions of polymorphisms in VKORC1 and CYP2C9 to intra- and inter-population differences in maintenance dose of warfarin in Japanese, Caucasians and African-Americans", Pharmacogenet Genomics, 16, pp.101~110 (2006)
36. Takahashi H, "5’-Flanking region polymorphisms of CYP2C9 and their relationship to S-warfarin metabolism in white and Japanese patients", Blood, 103, pp.3055~3057 (2004)
37. Sato C, "Postoperative bleeding in patients on antithrombotic therapy after gastric endoscopic submucosal dissection", World J Gastroenterol, 23, pp.5557~5566 (2017)
38. Furuhata T, "Postoperative bleeding after gastric endoscopic submucosal dissection in patients receiving antithrombotic therapy", Gastric Cancer, 20, pp.207~214 (2017)
39. Gotoda T, "Evaluation of the bleeding risk with various antithrombotic therapies after gastric endoscopic submucosal dissection", Endosc Int Open, 5, pp.E653~E662 (2017)
40. Harada H, "Continuous use of low-dose warfarin for gastric endoscopic submucosal dissection:a prospective study", Endosc Int Open, 5, pp.E348~E353 (2017)
41. Birnie DH, "Pacemaker or defibrillator surgery without interruption of anticoagulation", N Engl J Med, 368, pp.2084~2093 (2013)
42. Robinson M, "Postoperative low-molecular-weight heparin bridging is associated with an increase in wound hematoma following surgery for pacemakers and implantable defibrillators", Pacing Clin Electrophysiol, 32, pp.378~382 (2009)
43. Suzuki S, "Risk factors for bleeding after endoscopic submucosal dissection of colorectal neoplasms", World J Gastroenterol, 20, pp.1839~1845 (2014)

관련 논문AI추천